3650 results for «233»

Filter By

3650 results

Diversity in coronary artery disease treatment

22 May 2026 – From EuroPCR 2026

Focusing on the diversity in coronary artery disease treatment, this session highlights challenges ranging from maintaining interventional cardiology services during conflict to the influence of comorbidities such as type 2 diabetes mellitus on prognosis and risk assessment. It also presents clinical outcomes related to stent thrombosis...

Complication management in CTO PCI - Part 2

22 May 2026 – From EuroPCR 2026

This session focuses on managing complications during chronic total occlusion (CTO) PCI procedures. It presents challenging cases including artery perforations, donor vessel-related procedural difficulties, and intramural hematoma rescue guided by intravascular ultrasound (IVUS). Strategies to address in-stent CTO and the unpredictable nature of CTO PCI complications...

Left main PCI-complex procedures

22 May 2026 – From EuroPCR 2026

This session covers complex left main coronary artery PCI procedures that challenge standard algorithms. It includes tackling chronic total occlusions of the left main, managing spontaneous coronary artery dissection in patients on ECMO, handling stent dislodgement, and addressing complex trifurcation lesions, providing comprehensive insights into advanced...

Calcified lesions: when one dedicated device is not enough

22 May 2026 – From EuroPCR 2026

This session highlights the need for multiple dedicated devices in the treatment of calcified coronary lesions. It discusses combined orbital and rotational atherectomy techniques, debulking in complex high-risk patients, and the integration of atherectomy with intravascular lithotripsy systems. Emphasis is placed on physiology and imaging-guided approaches...

Innovative strategies in STEMI management

22 May 2026 – From EuroPCR 2026

This session presents innovative strategies in STEMI management, including the treatment of acute saphenous vein graft occlusion, primary PCI via the left internal mammary artery, and a two-step lesion debulking approach. It also covers hybrid drug-coated balloon strategies in complex multivessel disease and the emerging role...

Challenging cases in calcified lesions PCI

22 May 2026 – From EuroPCR 2026

This session addresses challenging cases in PCI of heavily calcified lesions. It covers unexpected complications such as silent shockwave failures, interventions in calcified Kawasaki disease, delayed coronary obstructions post-TAVI, and complex left main bifurcation lesions. The session underscores the perseverance required to successfully navigate these demanding...

EuroPCR 2026 – Long-term mortality following revascularisation for left main disease

20 May 2026

Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide. Among them is a meta-analysis of long-term data from 4 randomised trials investigating...

EuroPCR 2026 – Long-term mortality following revascularisation for left main disease

FAVOR III China: Angiographic quantitative flow ratio-guided coronary intervention - a multicentre, randomised, sham-controlled trial

04 Nov 2021

Nicola Ryan provides her take on this investigator initiated, multicentre, randomised, blinded, sham controlled trial compares clinical outcomes of QFR versus angiography guided strategies for the treatment of non-critical lesions in patients with stable or unstable angina or MI at least 72 hours prior to screening....

Nicola Ryan

Author

Nicola Ryan
FAVOR III China: A Sham-Controlled Randomized Trial Comparing QFR-Guided and Angiography-Guided PCI

Early intra-aortic balloon pump in heart failure complicated by cardiogenic shock: The Altshock-2 randomized clinical trial

31 Mar 2025

Mirvat Alasnag provides her take on the Altshock-2 randomized clinical trial which was presented by Alice Sacco at ACC.25 in Chicago.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Early intra-aortic balloon pump in heart failure complicated by cardiogenic shock: The Altshock-2 randomized clinical trial

Percutaneous transseptal transcatheter mitral valve replacement using a dedicated balloon-expandable valve: 1-year outcomes from the ENCIRCLE trial using the SAPIEN M3

27 Oct 2025

Jonathan Curio provides his take on the ENCIRCLE Trial presented by David Daniels at TCT 2025 in San Francisco.

Jonathan Curio

Author

Jonathan Curio
Percutaneous transseptal transcatheter mitral valve replacement using a dedicated balloon expandable valve: 1 year outcomes from the ENCIRCLE trial using the SAPIEN M3
Didn’t find what you were looking for?